118 related articles for article (PubMed ID: 20434445)
1. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha.
Rechtman MM; Har-Noy O; Bar-Yishay I; Fishman S; Adamovich Y; Shaul Y; Halpern Z; Shlomai A
FEBS Lett; 2010 Jun; 584(11):2485-90. PubMed ID: 20434445
[TBL] [Abstract][Full Text] [Related]
2. Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway.
Jhuang HJ; Hsu WH; Lin KT; Hsu SL; Wang FS; Chou CK; Lee KH; Tsou AP; Lai JM; Yeh SF; Huang CY
Oncotarget; 2015 Apr; 6(10):7788-803. PubMed ID: 25762623
[TBL] [Abstract][Full Text] [Related]
3. The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus.
Mouler Rechtman M; Burdelova EO; Bar-Yishay I; Ben-Yehoyada M; Fishman S; Halpern Z; Shlomai A
J Viral Hepat; 2013 Jan; 20(1):34-41. PubMed ID: 23231082
[TBL] [Abstract][Full Text] [Related]
4. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon.
Shlomai A; Shaul Y
Med Hypotheses; 2008; 71(1):53-7. PubMed ID: 18334285
[TBL] [Abstract][Full Text] [Related]
5. PGC-1alpha controls hepatitis B virus through nutritional signals.
Shlomai A; Paran N; Shaul Y
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16003-8. PubMed ID: 17043229
[TBL] [Abstract][Full Text] [Related]
6. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
7. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
8. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver.
Hu Z; Zhang Z; Kim JW; Huang Y; Liang TJ
J Virol; 2006 Feb; 80(3):1405-13. PubMed ID: 16415018
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
Protzer U; Seyfried S; Quasdorff M; Sass G; Svorcova M; Webb D; Bohne F; Hösel M; Schirmacher P; Tiegs G
Gastroenterology; 2007 Oct; 133(4):1156-65. PubMed ID: 17919491
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 inhibits HBV entry through NTCP down regulation.
Bouezzedine F; Fardel O; Gripon P
Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
[TBL] [Abstract][Full Text] [Related]
12. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
[TBL] [Abstract][Full Text] [Related]
13. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity.
Wang S; Qiu L; Yan X; Jin W; Wang Y; Chen L; Wu E; Ye X; Gao GF; Wang F; Chen Y; Duan Z; Meng S
Hepatology; 2012 Mar; 55(3):730-41. PubMed ID: 22105316
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of human La protein at Ser 366 by casein kinase II contributes to hepatitis B virus replication and expression in vitro.
Tang J; Zhang ZH; Huang M; Heise T; Zhang J; Liu GL
J Viral Hepat; 2013 Jan; 20(1):24-33. PubMed ID: 23231081
[TBL] [Abstract][Full Text] [Related]
15. The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector.
Shlomai A; Lubelsky Y; Har-Noy O; Shaul Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):619-23. PubMed ID: 19818740
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Hepatitis B virus replication by phospholipid scramblase 1 in vitro and in vivo.
Yang J; Zhu X; Liu J; Ding X; Han M; Hu W; Wang X; Zhou Z; Wang S
Antiviral Res; 2012 Apr; 94(1):9-17. PubMed ID: 22342889
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of host genes including hepatic fatty acid synthase in HBV-transgenic mice.
Zhang H; Li H; Yang Y; Li S; Ren H; Zhang D; Hu H
J Proteome Res; 2013 Jun; 12(6):2967-79. PubMed ID: 23675653
[TBL] [Abstract][Full Text] [Related]
18. The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription.
Shlomai A; Shaul Y
Biochem Biophys Res Commun; 2009 Apr; 381(4):544-8. PubMed ID: 19233123
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides targeting abhydrolase domain containing 2 block human hepatitis B virus propagation.
Ding X; Yang J; Wang S
Oligonucleotides; 2011; 21(2):77-84. PubMed ID: 21466387
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.
Wang YL; Liou GG; Lin CH; Chen ML; Kuo TM; Tsai KN; Huang CC; Chen YL; Huang LR; Chou YC; Chang C
PLoS One; 2015; 10(3):e0119625. PubMed ID: 25785443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
